Lonza To Acquire Large-Scale Biologics Mfg Site from Roche for $1.2 Bn 
By

By
Lonza has agreed to acquire a large-scale biologics manufacturing site in Vacaville, California, from Roche’s Genentech for $1.2 billion.  The Vacaville facility currently has a total bioreactor capacity of approximately…

BMS Completes $14-Bn Acquisition of Karuna Therapeutics 
By

By
Bristol Myers Squibb (BMS) has completed its $14-billion acquisition of Karuna Therapeutics, a Boston-based bio/pharmaceutical company specializing in neuroscience-based drugs. The acquisition was first announced in December 2023. The deal…

Gilead Completes $4.3-Bn Acquisition of CymaBay Therapeutics 
By

By
Gilead has completed its $4.3-billion acquisition of CymaBay Therapeutics, a Newark, California-based clinical-stage bio/pharmaceutical company. The deal was announced in February 2024.  CymaBay’s lead candidate is seladelpar, an oral drug…

AstraZeneca To Acquire Fusion Pharmaceuticals & Amolyt Pharma in Combined $3.4-Bn Deals 
By

By
AstraZeneca has agreed to acquire two companies in two separate deals: Fusion Pharmaceuticals, a Hamilton, Ontario, Canada-based clinical-stage bio/pharmaceutical company, in a $2.4-deal billion (includes $2 billion upfront), and Amolyt…

J&J Completes $2-Bn Acquisition of ADC Company Ambrx Biopharma 
By

By
Johnson & Johnson (J&J) has completed its acquisition of Ambrx Biopharma, a La Jolla, California-based bio/pharmaceutical company, for a total equity value of $2.0 billion. The deal was announced in…

Novo Nordisk To Acquire Cardior Therapeutics in $1.1-Bn Deal 
By

By
Novo Nordisk has agreed to acquire Cardior Pharmaceuticals, a Hanover, Germany-based bio/pharmaceutical company, in an EUR 1.025 billion ($1.1 billion) deal. The deal includes an undiclosed upfront payment and additional…

BMS Investing $400 M in New Sterile Drug-Product Mfg Facility 
By

By
Bristol Myers Squibb (BMS) has announced a $400-million investment at its Dublin, Ireland (Cruiserath) campus for the build and design of a sterile drug-product (SDP) manufacturing facility.   This will be…

BMS Completes $4.1-Bn Acquisition of Radiopharmaceutical Company RayzeBio 
By

By
Bristol Myers Squibb (BMS) has completed its $4,1-billion acquisition of RayzeBio, a San Diego, California-based clinical-stage radiopharmaceutical company, The acquisition was announced in January 2024.  RayzeBio has a position in…

Supplier News: Simtra, CordenPharma, CoreRx & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Simtra BioPharma Solutions, CordenPharma, CoreRx, Societal CDMO, Ritedose, and Experic.   Formulation Development/Drug Product Manufacturing * Simtra BioPharma To Invest $250 M In Sterile…

Partnering News: Novo Nordisk, AbbVie & More 
By

By
A roundup of bio/pharmaceutical partnering news from Novo Nordisk/Neomorph and AbbVie/OSE Therapeutics.  * Novo Nordisk, Neomorph in $1.46-Bn Molecular Glue Degraders Drug Deal * AbbVie, OSE Therapeutics In $713-M mAb Oncology…